<?xml version="1.0" ?>
<rss version="2.0">
<channel>
<title>BIOBUSINESS Inside Industry news from GEN</title><description>Details mergers and acquisitions, establishment of subsidiaries, grants and funding, and industry lawsuits.</description>
<lastBuildDate>Tuesday, February 09, 2010</lastBuildDate><link>http://www.genengnews.com/news/newslist.aspx?taxid=1</link>
<item>
<title>BioAlliance Pharma Announces Its Consolidated Turnover for 2009 a Doubling in Recurring Revenues</title>
<description></description>
<pubDate>Tuesday, February 09, 2010</pubDate>
<link>http://www.genengnews.com/news/bnitem.aspx?name=75126601</link>
</item>
<item>
<title>Ligand Announces Fourth Quarter and Full Year 2009 Consolidated Financial Results</title>
<description></description>
<pubDate>Tuesday, February 09, 2010</pubDate>
<link>http://www.genengnews.com/news/bnitem.aspx?name=75111438</link>
</item>
<item>
<title>Spectranetics to Hold 2009 Fourth Quarter Financial Results Conference Call on February 18</title>
<description></description>
<pubDate>Tuesday, February 09, 2010</pubDate>
<link>http://www.genengnews.com/news/bnitem.aspx?name=75107939</link>
</item>
<item>
<title>Teva Acquires Marketing Rights for Oral Laquinimod in the Nordic and Baltic Regions</title>
<description></description>
<pubDate>Monday, February 08, 2010</pubDate>
<link>http://www.genengnews.com/news/bnitem.aspx?name=75027857</link>
</item>
<item>
<title>Emerging Healthcare Advances Toward Sealing ThromboVision Deal</title>
<description></description>
<pubDate>Monday, February 08, 2010</pubDate>
<link>http://www.genengnews.com/news/bnitem.aspx?name=75026641</link>
</item>
<item>
<title>Alnylam Receives Notice of Allowance from United States Patent and Trademark Office for New Patent Broadly Covering RNAi Therapeutics</title>
<description></description>
<pubDate>Monday, February 08, 2010</pubDate>
<link>http://www.genengnews.com/news/bnitem.aspx?name=75025433</link>
</item>
</channel>
</rss>
